Return on Equity (ROE)
Updated 392h ago
Sector Performance
27th percentilePLD
6.8%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders' equity — a 6.8% ROE means PLD earned $0.068 for every $1 of equity.
This is well below the sector median of 14.2%, placing PLD in the 25th percentile among its peers, indicating weaker profitability relative to the industry. The year-over-year and quarter-over-quarter changes are both reported as N/A, and the trend direction over the last eight quarters is also N/A, so no recent trajectory is available to assess. The combination of a low ROE level with no trend data suggests limited information for evaluating momentum, but the below-median return raises a caution flag about capital efficiency. This metric contradicts a strong bullish case and supports the overall NEUTRAL verdict, as the underperformance relative to peers offsets any positive signals from other factors.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about PLD?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are PLD's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master PLD's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full PLD research report →PLD
6.8%
Sector Median
13.8%
Sector Avg
31.4%
How PLD's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.